Tsuruha Holdings Inc.

3391.T
Pharmaceutical Retailers
2026/01/16 Updated
Market Cap: $7.5B (¥1.2T)
Stock Price: $16.41 (¥2,600)
Exchange Rate: 1 USD = ¥158.48

Notice Regarding Recording of Extraordinary Income (Gain on Step Acquisition)

In the fourth quarter of the fiscal year ending February 2026, Tsuruha Holdings Inc. plans to record an extraordinary income of 10,583 million yen from the gain on step acquisition associated with the consolidation of Welcia Holdings Co., Ltd. as a consolidated subsidiary.

Importance:
Page Updated: January 8, 2026
IR Disclosure Date: January 8, 2026

Key Figures

  • Gain on Step Acquisition: 10,583 million yen (extraordinary income planned)
  • Date of Business Integration Completion: 2025-12-01
  • Target Company: Welcia Holdings Co., Ltd. (Consolidated Subsidiary)

AI要約

Overview of Extraordinary Income Recording

The Company completed a business integration with Welcia Holdings Co., Ltd. on December 1, 2025, and made the company a consolidated subsidiary. Accordingly, an extraordinary income of 10,583 million yen related to the gain on step acquisition is expected to be recorded in the consolidated accounting period for the fourth quarter of the fiscal year ending February 2026.

Impact on Financial Results

The recording of this extraordinary income is reflected in the revision of the full-year consolidated earnings forecast and year-end dividend forecast for the fiscal year ending February 2026. For details, please refer to the announcement titled "Notice Regarding Revision of Full-Year Consolidated Earnings Forecast and Year-End Dividend Forecast" released on the same day.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.